Business
Burcon Announces Fiscal 2019 Results and Reviews Operations
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2019) - Burcon NutraScience Corporation...
About this update from Burcon Nutrascience Corporation
[{"type":"text","content":"Burcon Announces Fiscal 2019 Results and Reviews OperationsVancouver, British Columbia--(Newsfile Corp. - July 2, 2019) - Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, reported results for the year ended March 31, 2019. \"Fiscal 2019 proved to be a turning point in consumer appetites for plant-based foods and a watershed moment in Burcon's history,\" said Johann F. Tergesen, Burcon's president and chief executive officer. He added: \"Looking back on the year, our team did a great job of focusing on and achieving our number one priority, and as a result we are now driving forward and building a first of its kind commercial-scale plant-protein production facility, where we will produce our unique pea and canola proteins directly through our just-announced partnership. As the world awakens to the opportunity of a better way to feed the planet, Burcon, with twenty years of expertise in plant-protein research, is ideally positioned to capitalize from the moment. We look forward to offering our pea and canola protein products to customers and consumers who choose to defy convention, embrace innovation, and who simply want to feel great about their health and sustainability.\"Fiscal 2019 Operational HighlightsPursued ongoing discussions, negotiations and participated in due diligence visits associated with partnering activities;Burcon's Winnipeg Technical Centre undertook Peazazz® applications work and provided significant quantities of samples throughout the year in response to requests from and in support of analytical work conducted by potential commercialization partners as well as for food and beverage companies who have expressed an interest in Peazazz® and Peazac®; andReceived two U.S. patent grants during the fiscal year, including one for the production of Peazazz® and one for soy. The Peazazz® patent granted by the U.S. Patent and Trademark Office relates to a process for producing pea protein isolates with reduced astringency in low pH solutions. The company's patent portfolio now comprises 262 issued patents in various countries, including 67 in the U.S., as well as more than 265 active patent applications, including 42 additional U.S. patent applications.Subsequent to the year-end, the Company announced / completed t...